Privy

Privy is a women-led company dedicated to enhancing women's health through innovative solutions, focusing on bladder leaks and infections with its flagship product, the Finess® softpatch. Founded in 2014, Privy is based in Los Angeles, US, and specializes in feminine care products. The company has completed 4 deals, with its most recent funding round being an Angel round in September 2020, raising USD 1. 970 mn, which is the total amount raised to date.

The company does not have any known subsidiaries or parent companies, nor has it undergone any notable business pivots. The founders' background details are currently not available. Privy® offers innovative solutions for women's health, particularly addressing bladder leaks, UTIs, and yeast infections. The Finess® softpatch is the first FDA-cleared over-the-counter product designed to prevent light to moderate bladder leaks.

It allows active women to engage in daily activities without discomfort or anxiety. The product is environmentally friendly, generating 95% less landfill waste than traditional feminine care products, and is marketed primarily in the United States with plans for international expansion. Privy generates revenue through direct-to-consumer sales, leveraging retail partnerships and online platforms. The Finess® softpatch is strategically placed within the feminine care aisle, appealing to consumers seeking modern solutions.

This pricing strategy aligns with the growing demand for women's health products, promoting brand loyalty and facilitating repeat purchases. Privy plans to expand its product line with new offerings aimed at addressing additional women’s health issues in the next 12 months. The company is also targeting international markets for expansion, specifically aiming to launch in Europe and Canada by the end of 2022. The recent Angel round funding raised in September 2020 will support these initiatives and facilitate market entry strategies.